Pharis Mohideen
2021 - DBV Technologies S.A.
In 2021, Pharis Mohideen earned a total compensation of $1.2M as Chief Medical Officer at DBV Technologies S.A., a 16% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $141,906 |
|---|---|
| Option Awards | $450,190 |
| Salary | $466,796 |
| Stock Awards | $56,284 |
| Other | $81,603 |
| Total | $1,196,778 |
Mohideen received $466.8K in salary, accounting for 39% of the total pay in 2021.
Mohideen also received $141.9K in non-equity incentive plan, $450.2K in option awards, $56.3K in stock awards and $81.6K in other compensation.
Rankings
In 2021, Pharis Mohideen's compensation ranked 8,124th out of 12,415 executives tracked by ExecPay. In other words, Mohideen earned more than 34.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,124 out of 12,415 | 35th |
Division Manufacturing | 3,590 out of 5,505 | 35th |
Major group Chemicals And Allied Products | 1,594 out of 2,375 | 33rd |
Industry group Drugs | 1,418 out of 2,096 | 32nd |
Industry Biological Products, Except Diagnostic Substances | 315 out of 449 | 30th |
Source: SEC filing on April 25, 2022.
Mohideen's colleagues
We found two more compensation records of executives who worked with Pharis Mohideen at DBV Technologies S.A. in 2021.